Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has launched C10 Cryptocurrency Asset Treasury (DAT) purchases amidst a recent market pullback. The past 48 hours saw $16 billion in leveraged positions liquidated, causing significant declines in paper wealth. However, Qualigen remains optimistic, viewing the pullback as a necessary “stress test” for the market. The company plans to strategically purchase assets starting next week, leveraging their SMART Investment Framework to navigate the downturn. Additionally, Qualigen is eyeing high-quality assets and strategic mergers to capitalize on the market correction and expand their industry footprint. Despite short-term challenges, the company remains focused on the long-term potential of the crypto market.

Read more at GlobeNewswire: Qualigen Therapeutics Announces the Official Launch of C10